How long is recuperation after surgery for osteochondritis dissecans?

How long is recuperation after surgery for osteochondritis dissecans?

How long is recuperation after surgery for osteochondritis dissecans?

Patients with osteochondritis dissecans in the knee will need to walk on crutches for six to eight weeks after surgery to ensure that the lesions heal properly. After an additional two to four months of physical therapy, most patients will be able to walk without restrictions.

Do you need a cast after osteochondritis surgery?

Osteochondritis Dissecans Surgery Recovery On average, it can take about eight weeks before bones and soft tissues heal. You will need to wear a cast during this time. Eventually, you may need to go to physical therapy to rebuild strength and to help heal bones, muscles, ligaments and tendons.

How common is osteochondritis dissecans elbow?

Epidemiology. Elbow OCD presents typically in adolescent athletes engaged in repetitive overhead or upper extremity weight-bearing activities (e.g., baseball, tennis, volleyball, weight lifting and gymnastics). The prevalence of OCD of the humeral capitellum was 3.4% among more than 2000 adolescent baseball players[2].

How long is osteochondral defect surgery?

Small osteochondral lesions may only require the first few steps, whereas large lesions usually require more complex procedures. Spinal anesthesia typically is given to numb you from the waist down and you usually are sedated so you sleep through the procedure. Surgery can last up to two hours.

What does OCD elbow feel like?

Pain and swelling in the affected joint that worsens with activity. Locking and “catching” of the affected joint. A “giving way” sensation in the affected area. Changes in the range of motion in the joint.

How successful is OCD surgery?

This study suggests osteochondral allografts are an option for patients with juvenile OCD. Similarly, Murphy et al. [56] reported on 26 patients with juvenile OCD lesions (average age, 16.4 years) treated with osteochondral allografts and found an 85 % success rate at an average of 8.9 years of follow-up.